Reggie E Duerst

  • 1747 Citations
1985 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Application of Hematopoietic Stem Cell Transplantation to treat pediatric diseases--hematologic and immunologic diseases, select congenital metabolic diseases as well as high-risk malignancies. Expand the indications for Stem Cell transplantation as cellular therapy for other diseases/organ dysfunction. Utilize Stem Cell Transplantation as a platform for cellular therapies for inherited and acquired diseases.

Foster collaborative studies to improve the immunologic recovery and quality of life for patients undergoing Hematopoietic Stem Cell Transplantation.

Improving outcomes for both quality and quantity of survival after Hematopoietic Stem Cell Transplantation.

Certifications and Licenses

Pediatrics
Pediatric Hematology-Oncology

Training Experience

1982Residency, University of Rochester
1985Fellowship, University of Rochester

Education/Academic qualification

MD, University of Wisconsin-Milwaukee

… → 1979

Research interests

  • Blood Cancer (leukemia and lymphomas)
  • Brain Cancer / Nervous System Cancer
  • Hematology
  • Immune Regulation
  • Regenerative Medicine
  • Stem Cells
  • Transplantation

Fingerprint Dive into the research topics where Reggie E Duerst is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

  • 1747 Citations
  • 57 Article
  • 3 Review article
  • 2 Letter

Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease

Broglie, L., Rademaker, A., Galvin, J., Ray, A., Tse, W. T., Duerst, R., Schneiderman, J., Kletzel, M. & Chaudhury, S., Sep 2018, In : Hematology/ Oncology and Stem Cell Therapy. 11, 3, p. 169-174 6 p.

Research output: Contribution to journalArticle

  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression

    Jacobsohn, D. A., Loken, M. R., Fei, M., Adams, A., Brodersen, L. E., Logan, B. R., Ahn, K. W., Shaw, B. E., Kletzel, M., Olszewski, M., Khan, S., Meshinchi, S., Keating, A., Harris, A., Teira, P., Duerst, R. E., Margossian, S. P., Martin, P. L., Petrovic, A., Dvorak, C. C. & 29 others, Nemecek, E. R., Boyer, M. W., Chen, A. R., Davis, J. H., Shenoy, S., Savasan, S., Hudspeth, M. P., Adams, R. H., Lewis, V. A., Kheradpour, A., Kasow, K. A., Gillio, A. P., Haight, A. E., Bhatia, M., Bambach, B. J., Haines, H. L., Quigg, T. C., Greiner, R. J., Talano, J. A. M., Delgado, D. C., Cheerva, A., Gowda, M., Ahuja, S., Ozkaynak, M., Mitchell, D., Schultz, K. R., Fry, T. J., Loeb, D. M. & Pulsipher, M. A., Oct 2018, In : Biology of Blood and Marrow Transplantation. 24, 10, p. 2040-2046 7 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations

    Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant

    Broglie, L., Helenowski, I., Jennings, L. J., Schafernak, K., Duerst, R. E., Schneiderman, J., Tse, W. T., Kletzel, M. & Chaudhury, S., Sep 1 2017, In : Pediatric Blood and Cancer. 64, 9, e26493.

    Research output: Contribution to journalArticle

  • 1 Scopus citations
  • 1 Scopus citations